Table 1 51 Reported cases of MAHA associated with breast cancer
Author | Age | Bone marrow metastasis | Intervention | Prognosis (survival time) | Notes |
|---|---|---|---|---|---|
Pendse et al. (2014) | 69 | + | None | Soon death | Â |
Kok et al. (2014) | 43 | Bone meta only | Discontinuation of GEM | Recovery | s/o GEM induced MAHA |
Lechner and Obermeier (2012) (case reports review included 36 breast cancer cases) | Average 54 (19–82) | 24/36 | Each cases | 4 months (chemotherapy) Half a month (no treatment) |  |
George (2011) | 52 | + | Plasma exchange | 3Â days | Death due to micro thrombi in multiple organs |
Himmelmann and Schefer (2009) | 66 | – | None | 10 days |  |
Lockhart (2001) | Unknown (middle age) | + | Chemotherapy | Survival for more than 1Â year | Â |
Fontana et al. (2001) (Case A) | 69 | + | Chemotherapy | No description of death | Â |
Fontana et al. (2001) (Case B) | 62 | + | None | 4Â days | Â |
Fontana et al. (2001) (Case C) | 60 | + | None | 1Â day | Death due to pulmonary embolism |
Ataga and Graham (1999) | 46 | + | None | 7Â days | Â |
Narita et al. (1997) | 45 | + | Chemoendcrinetherapy | No description of death | Â |
Nordstrom and Strang (1993) | 58 | + | Chemotherapy | 12Â months | Â |
Bastecky et al. (1992) | 28 | + | None | 10Â days | Death due to pulmonary embolism |
Collins et al. (1991) | 54 | + | Chemotherapy and plasma exchange | No description of death | Â |
N Engl J Med Case Record. (1984) | 53 | Unknown | Plasma exchange | 4Â days | Death due to tumor embolism in liver |
Own case 2015 | 54 | − | Chemotherapy | 13 months |  |